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ABSTRACT
In pregnancy, changes in maternal calcium (Ca) economy occur to satisfy fetal Ca demand. It is unclear whether maternal mineral
reserves facilitate these requirements and no data exist from sub-Saharan Africa. The aim was to determine skeletal changes with
peripheral quantitative computed tomography (pQCT) and bone biochemistry between early second and third trimesters. Pregnant
rural Gambians aged 18 to 45 years (n = 467) participating in a trial of antenatal nutritional supplements (ISRCTN49285450) had pQCT
scans and blood collections at mean (SD) 14 (3) and 31 (1) weeks’ gestation. Outcomes were pQCT: radius/tibia 4% total volumetric
bone mineral density (vBMD), trabecular vBMD, total cross-sectional area (CSA), 33%/38% radius/tibia cortical vBMD, bone mineral
content (BMC), total CSA; biochemistry: collagen type 1 cross-linked β-C-telopeptide (β-CTX), type 1 procollagen N-terminal (P1NP),
parathyroid hormone (PTH), and 1,25(OH)2D. Independent t tests tested whether pooled or within-group changes differed from
0. Multiple regression was performed adjusting for age. Data for change are expressed as mean (confidence interval [CI] 2.5,
97.5%). Radius trabecular vBMD, cortical vBMD, and BMC increased by 1.15 (0.55, 1.75)%, 0.41 (0.24, 0.58)%, and 0.47 (0.25, 0.69)%.
Tibia total and trabecular vBMD increased by 0.34 (0.15, 0.54)% and 0.46 (0.17, 0.74)%, while tibia cortical vBMD, BMC, and cortical
CSA increased by 0.35 (0.26, 0.44)%, 0.55 (0.41, 0.68)% and 0.20 (0.09, 0.31)%, respectively. CTX, PTH, and 1,25(OH)2D increased by
23.0 (15.09, 29.29)%, 13.2 (8.44, 19.34)%, and 21.0 (17.67, 24.29)%, while P1NP decreased by 32.4 (−37.19, −28.17)%. No evidence
of mobilization was observed in the peripheral skeleton. Resorption, although higher in late versus early gestation, was lower
throughout pregnancy compared with non-pregnant non-lactating (NPNL) in the same community. Formation was lower in late
pregnancy than in early, and below NPNL levels. This suggests a shift in the ratio of resorption to formation. Despite some evidence
of change in bone metabolism, in this population, with habitually low Ca intakes, the peripheral skeleton was not mobilized as a Ca
source for the fetus. © 2021 crown copyright. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of
American Society for Bone and Mineral Research (ASBMR). The article published with the permission of the Controller of HMSO
and the Queen’s Printer of Scotland.
KEY WORDS: ANALYSIS/QUANTIFICATION OF BONE; BONE QCT/μCT; EPIDEMIOLOGY; GENERAL POPULATION STUDIES; AGING; BONE MODELING
AND REMODELING; BIOCHEMICAL MARKERS OF BONE TURNOVER
Introduction
During pregnancy, the fetus is reliant on themother to satisfyits nutrient requirements. As fetal calcium (Ca) accretion
increases across gestation from 50 mg/d at 20 weeks to
330 mg/d at 35 weeks(1) and at birth the newborn skeleton con-
tains 20 to 30 g Ca,(2) it is plausible that these high demands may
result in bone mineral mobilization from the maternal skeleton.
In the literature, there are conflicting reports concerning bone
mineral mobilization during pregnancy.(3,4) The small number
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of studies that used X-ray-based techniques to explore
pregnancy-related skeletal changes typically have either
obtained whole-body and regional dual-energy X-ray absorpti-
ometry (DXA) scans before and after pregnancy or have scanned
the forearm during pregnancy.(5–20) Both of these approaches
have limitations because postpartum measures are confounded
by lactation and because DXA cannot distinguish between corti-
cal and trabecular bone, which may be differentially affected by
pregnancy. Peripheral quantitative computed tomography
(pQCT), however, allows for the measurement of compartment-
specific measures of volumetric bone mineral density (vBMD)
and, because it involves minimal exposure to ionizing radiation,
is suitable for studies during pregnancy.(21,22) Recently, in a pop-
ulation of predominately white women in Cambridge, UK, we
found evidence of pregnancy-related decreases in maternal
vBMD at the distal tibia using both pQCT (total and trabecular
vBMD) and high-resolution pQCT (total and cortical vBMD).(22)
No studies have been conducted in sub-Saharan Africa or in
other low- and middle-income countries where poor nutritional
status and micronutrient deficiencies are common and where
the demands on the maternal skeleton may be greater because
of repeated cycles of pregnancy and lactation. Women in rural
areas of The Gambia, West Africa, have a habitually low calcium
intake (approximately 350 mg/d) and often have many pregnan-
cies with long lactation periods during their lifetime. Therefore,
the aim of the current study was to determine whether
pregnancy-related skeletal changes occur in rural Gambian
women using pQCT and biomarkers of bone turnover. The pri-
mary objective was to determine if total and trabecular vBMD
at the radius and tibia decrease during pregnancy and whether
this is modified by maternal nutritional supplementation. The
secondary objective was to consider the effect of pregnancy
andmaternal supplementation on other skeletal pQCTmeasures
and markers of bone turnover (BTMs).
Materials and Methods
Recruitment
The data presented here were collected as part of a bone-
focused add-on study to The Early Nutrition and Immune
Development (ENID) Trial (ISRCTN49285450).(23) ENID was a
longitudinal randomized controlled trial of nutritional supple-
mentation in the rural West Kiang region of The Gambia, West
Africa, designed to investigate the effects of antenatal and
infant nutritional supplementation on infant immune develop-
ment. The add-on study (ENID-Bone) was approved by the Joint
Gambian Government/MRC The Gambia Ethics Committee
(project number SCC1126v2; add-on L2009.66). Recruitment
into ENID took place in all 36 villages registered within the West
Kiang Demographic Surveillance System (DSS).(24) Inclusion cri-
teria for the study were age 18 to 45 years, pregnant <20 weeks
on ultrasound assessment, and resident in the West Kiang DSS
area. Exclusion criteria were currently being enrolled in another
MRC study and severe anemia at booking (hemoglobin
[Hb] <7 g/dL). All women entering the ENID trial were invited
to participate in the ENID-Bone add-on study; our analyses
comprise women with pQCT scans of usable quality performed
on two occasions during pregnancy as part of the ENID-Bone
add-on. These were at an initial booking visit (booking
14 weeks pregnancy) and at approximately 30 weeks’ gesta-
tion (P30) as determined by ultrasonography.(23) Data included
in the analyses presented here are for a subset of women who
had the pair of pQCT scans performed on the same instrument
to minimize any calibration differences between the two scan-
ners in use in the research facility (described below). Informed
consent was obtained by trained field workers with written
consent obtained through either a signature or a thumb print.
Supplement groups in the ENID trial
Each participant in ENID was randomized into the trial to start
supplementation immediately after the booking visit, and sup-
plementation continued until delivery. Randomization to supple-
ment group was by an automated system.(23) The four antenatal
supplements (Supplemental Table S1) were iron-folic acid (IFA;
given as per standard antenatal practice in The Gambia); multi-
micronutrients (MMN); lipid-based protein-rich energy and pro-
tein (PE); and a lipid-based PE + MMN, which is these two sup-
plements combined.(23)
Anthropometry
Detailed maternal anthropometry was collected at each visit.
Height (cm) was obtained without footwear to the nearest
0.1 cm by wall-mounted stadiometer (Seca GmbH, Hamburg,
Germany). Weight (kg) was measured to the nearest 0.1 kg using
a digital scale, with participants wearing light clothing without
footwear (Seca GmbH). Limb length measurements were
obtained to the nearest 0.1 cm using a tape measure: tibial
length from the distal edge of the medial malleolus to the tibial
plateau; ulna length from the end of the olecranon to the distal
end of the ulnar styloid process.
Bone densitometry
The research facility in The Gambia has two pQCT instruments:
XCT 2000L and XCT 2000 (Stratec Medizintechnik, Pforzheim,
Germany). For this longitudinal study, the two scans for each
individual were obtained as far as possible on the same instru-
ment. pQCT scans of the non-dominant radius and tibia were
performed with a voxel size of 0.5 mm and slice thickness of
2 mm, at the radius (at 4% and 33% of the limb length proximal
to the distal endplate) and tibia (at 4% and 38% of the limb
length proximal to the distal endplate). CT scan speed was
30 mm/s and scout view scan speed was 40 mm/s. pQCT scans
were processed using the manufacturer’s software (Stratec XCT
version 6.2): at 4% sites CALCBD analysis contour mode 1, peel
mode 1 at a threshold of 180 mg/cm3 was used with trabecular
bone being defined as the inner area of 45% of the total cross-
sectional area (CSA). At cortical sites, a threshold of 710 mg/cm3
was selected in conjunction with CORTBD separation mode
1 and measures of cortical bone mineral content (BMC), vBMD,
cortical CSA, and thickness derived. Total CSA was defined at
proximal sites at a threshold of 280 mg/cm3. Scans were qualita-
tively graded by visual inspection to assess their suitability for
longitudinal analysis: scan slices with excessive movement or
other artifacts and scout views that did not match longitudinally
were excluded. Calibration of the XCT systems was performed
on a routine basis with the manufacturer’s phantom: daily
quality-assurance scans and weekly quality-control scans were
performed throughout the study period to test scanner perfor-
mance. Previous studies at our site found the inter-operator
precision to be 0.3% to 1.8% for bone outcome measures at
the tibia and 1.1% to 6.4% at the radius by performing two
repeat scans on 30 Gambian participants. Participants were
exposed to low doses of ionizing radiation; a set of radius/tibia
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scans had an effective dose equivalent to <3.2 μSv per visit,(25)
less than half background radiation levels.
Laboratory measures
Venous blood samples were collected into lithium heparin blood
tubes after an overnight fast. Plasma was separated by centrifu-
gation at 1800g for 10 minutes at 4C, stored at −80C, and sub-
sequently transported to the MRC Elsie Widdowson Laboratory
(Cambridge, UK) on dry ice and stored at −80C. Blood was pro-
cessed as EDTA plasma for parathyroid hormone (PTH) analysis
and as lithium heparin plasma for bone turnover markers
(P1NP and collagen type 1 crosslinked β-C-telopeptide [β-CTx])
and other analytes relating to calcium, phosphorus, and vitamin
D metabolism (calcium, phosphate, magnesium, albumin, creat-
inine, 1,25-dihydroxyvitamin D (1,25[OH]2D), total alkaline phos-
phatase (TALP). Corrected calcium was derived as described by
Payne and colleagues.(26) A subset was selected for the analysis
of CTx, P1NP, 1,25(OH)2D, and PTH due to limited volume and
the expense of the assays. The samples analyzed were selected
to ensure the proportions were balanced across the supplement
groups (Supplemental Table S2). Urine was collected in acid-
washed containers over 24 hours and kept cool in boxes with
freezer packs and returned to the lab for mixing and freezing
the next day. Aliquots were acidified with concentrated HCl
(10 μl/mL) and stored at−20C before transport to EWL and then
at−80C before analysis. The details of the assays used are given
in the supplemental material, as are the numbers of samples ana-
lyzed for each plasma analyte (Supplemental Table S2). Urinary
data from women with complete collections at booking and
P30 are presented in the supplemental material (n = 421; Supple-
mental Table S3). Reference data from a separate group of non-
pregnant, non-lactating (NPNL) women aged 30 to 45 years
living in the same region of rural Gambia and obtained from
assays conducted in the same laboratory are provided for con-
text (n = 136; Supplemental Table S4) (A Prentice, unpublished
data, personal communication).
Post hoc powering for pQCT analysis
At the time of planning the analysis for this study, no comparable
pQCT data were available in the literature to perform a power
calculation. Instead, post hoc powering was used, based on a
previous study where changes in DXA-measured size-adjusted
BMC at the lumber spine of 2.6% (SD 4.2%) occurred between
pre-pregnancy and 2 weeks postpartum.(18) This determined
that a sample size of 35 participants would be required to detect
within-group change in BMD from booking to 30 weeks preg-
nancy of a similar magnitude with a power of 0.9 and signifi-
cance of 0.05.(27) Since that time, we have shown in a UK pQCT
study comparing pregnant to NPNL women that significant
within-group differences could be observed with n = 35.(22) Thus
the number of scans available from the ENID-Bone study
(n = 467) was more than sufficient to detect changes of a similar
magnitude.
Data analyses
All analyses were performed using R version 3.3.2 (R Foundation
for Statistical Computing, Vienna, Austria; https://www.r-project.
org/) with dplyr (version 0.8.3) for data manipulation.(28) Baseline
characteristics are presented with data given as mean (SD),
except for parity, which is expressed as median (IQR) and also
in categories as n (%). Natural logarithms of all variables except
age were calculated to normalize the data distributions and to
describe proportional (percentage) differences between (and
within) groups.(29) Between-visit change in each variable was
expressed as a sympercent ([difference/mean]*100), derived by
subtracting loge(booking) from loge(P30) and multiplying by
100.(29)
ANOVA with post hoc Tukey test was used to test for signifi-
cant differences between the supplement groups at booking.
Independent t tests, equivalent to paired t tests, were used to
determine whether the mean between-visit change in each var-
iable was significantly different from zero. Multiple regression
was used to explore the extent of between-visit change after
adjusting for maternal age at booking. Maternal age at booking
(in years) was included in the models centered on the mean
age of the participants. This allows the intercepts from the
models to be interpreted as the between-visit change related
to pregnancy and the beta-coefficient for age as the sympercent
difference in change per year of maternal age. No additional
adjustment for parity wasmade becausematernal age and parity
were highly correlated in this cohort (r = 0.72). There were no sig-
nificant differences betweenwomen for whom this was their first
pregnancy and those who had more pregnancies. We also
looked at splitting the cohort on the basis of age (<30 years
and >30 years), but this also had little effect. A secondary analy-
sis to explore whether pregnancy-related change differed
between supplement group and the standard care was per-
formed by adding a categorical supplement variable to the
above model, the beta-coefficients for each supplement group
representing the sympercent difference in between-visit change
compared with IFA.
Results
A total of 875 women were recruited into the main ENID Trial, of
whom 811 went on to participate in the ENID-Bone add-on study.
A subset ofwomen (n= 564) had pQCT scans of usable quality per-
formed on two occasions during pregnancy 116 (SD 24) days
apart; of those, 467 had a pair of pQCT scans performed on the
same instrument. Table 1 presents the descriptive data at booking
for the subset of women (n = 467) included in the analyses and
those recruited into ENID-Bone who were not included (n = 344).
Women in these two subsets did not differ significantly by age,
though women without longitudinal scans data were slightly
heavier (p < .01) and had a lower parity (p < .05) (Table 1). Women
in the subset presented in this article were 14.0 (SD 3.4) weeks
pregnant at booking, which was not substantially different from
that of the main trial (13.8 [SD 3.3] weeks).(30) In our sample, preg-
nant women gained 5.3 (3.0) kg between booking and P30.
Plasma biochemistry was available for the subset of
467 women with longitudinal pQCT scans (Table 2), although
the numbers with data at each pregnancy visit differed for each
analyte (Supplemental Table S2). The summary data for the 4%
distal and 33%/38% proximal sites at the radius/tibia and for
the plasma analytes are in Table 2 for all participants included
in this analysis and stratified by supplement group in Table 3.
Urine data were also available for 421 women at both visits
and are summarized in Supplemental Table S3. The plasma and
urine data for the NPNL reference group are provided in Supple-
mental Table S4. There were significant differences (p < .001)
between the plasma biochemistry for the pregnant women com-
pared with these NPNL women: higher 1,25(OH)2D and lower
CTX, PTH, albumin, and magnesium concentrations at both
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booking and P30; lower phosphate at booking only; and higher
TALP plus lower P1NP and calcium concentrations at P30 only.
The 24-hour urinary phosphate and creatinine outputs of the
pregnant women were lower than NPNL women at both time
points (p < .002 and p < .001, respectively), whereas urinary cal-
cium output was higher at booking (p = .02) but lower at P30
(p = .03). These differences remained when expressed relative
to creatinine output, with the effect size reduced, except the
ratio for magnesium was higher at both booking and P30
(p < .001). No significant differences were found at booking
between the supplement groups for any characteristic, bone
outcome, or biochemistry measure.
Unadjusted analysis
Independent t tests revealed significant between-visit changes
in several pQCT bone measures (radius and tibia), all plasma bio-
chemistry (with the exception of corrected Ca), and all urinary
biochemistry except magnesium (Mg; Table 2, Supplemental
Table S3). Small, but statistically significant, increases were found
in vBMD and related measures at distal and proximal sites of
both the radius and tibia with increases in CTX, TALP, PTH, 1,25
(OH)2D, and phosphate concentrations and decreases in P1NP,
albumin, Ca, and Mg concentrations. There were also decreases
in the urinary mineral and creatinine outputs between booking
and P30 (Supplemental Table S3). No significant changes in bone
geometry were observed at these sites, except for an increase in
cortical CSA at the proximal tibia (Table 2).
Stratifying these data by maternal supplement group
(Table 3), the magnitudes of the changes remained small and
positive for the bone measures, with the effect sizes slightly
attenuated. At the distal sites, the increases were significant at
the radius for total vBMD in the MMN group and for trabecular
vBMD in the PE + MMN group, while the significant increases
at the tibia were for total and trabecular vBMD in the PE + MMN
group. At the proximal sites, increases in cortical vBMD and BMC
were significant at both sites in all groups, except at the proximal
radius of the PE group (Table 3). Similarly, the changes in the bio-
chemistry after stratification by supplement group remained
mostly consistent with the overall pattern. This was with the
exception of the increases in CTX, PTH, and plasma phosphate,
which were not significant in the PE group, nor CTX and urinary
Mg and creatinine outputs within MMN. Plasmamagnesium only
decreased significantly in the protein-containing supplement
groups and plasma phosphate did not decrease in the PE
+ MMN group (Table 3).
Adjusted analyses
After age adjustment, significant increases were found at distal
sites in radial and tibial trabecular vBMD (1.15 [0.55, 1.75]% and
0.46 [0.17, 0.74]%, respectively) and in tibial total vBMD (0.34
[0.15, 0.54]%) (Fig. 1). No significant changes in total CSA were
observed at distal sites. At proximal sites, small but significant
increases in cortical outcomes were observed. Radius cortical
vBMD and BMC increased by 0.35 (0.26, 0.44)% and 0.55 (0.41,
0.68)%, respectively, whereas tibia cortical vBMD and BMC
Table 1. Descriptive Statistics at Booking Visit for the Subset of Women With Longitudinal pQCT Scans and the Larger Study Population
Women with longitudinal pQCT Women without longitudinal pQCT
n = 467 n = 344
Age (years) 29.7 (6.5) 29.4 (7.1)
Parity, median (IQR)g 4 (2, 6) 4 (1, 6)d
Nulliparous 40 (8.7%) 44 (13.0%)
Parity 1–4 203 (44.3%) 157 (46.4%)
Parity 5–6 116 (23.3%) 71 (21.0%)
Parity 7+ 99 (21.6%) 66 (19.5%)
Weight at booking (kg) 54.8 (9.2) 56.6 (10.6)b
Height (cm) 161.7 (5.8) 162.0 (6.0)
Sitting height (cm) 80.2 (2.9) 80.1 (3.8)
Total n = 467
IFA MMN PE PE + MMN
n = 123 n = 119 n = 112 n = 113
Age (years) 29.2 (6.3) 29.7 (6.2) 29.6 (6.4) 30.3 (7.0)
Parity, median (IQR) 4 (2, 6) 4 (2, 6) 4 (2, 6) 5 (3, 7)
Nulliparous 13 (10.7%) 10 (8.5%) 11 (10.5%) 6 (6.7%)
Parity 1–4 50 (41.3%) 58 (49.2%) 46 (43.8%) 29 (32.2%)
Parity 5–6 37 (30.6%) 27 (22.9%) 25 (23.7%) 27 (30%)
Parity 7+ 21 (17.4%) 23 (19.5%) 23 (21.9%) 28 9 (31.1%)
Weeks pregnant 14.2 (3.5) 13.8 (3.7) 14.0 (3.2) 13.9 (3.3)
Weight at booking (kg) 54.7 (8.7) 54.2 (9.8) 55.7 (9.2) 54.5 (9.0)
Weight change (booking to P30, kg) 4.9 (2.9) 5.5 (3.0) 5.4 (3.0) 5.5 (3.1)
Height (cm) 161.9 (6.3) 161.8 (5.7) 162.0 (5.8) 161.2 (5.4)
Sitting height (cm) 80.3 (2.8) 80.3 (2.9) 80.2 (3.2) 80.3 (2.8)
IFA = iron folate; MMN = multiple micronutrients; PE = protein energy; PE + MMN = protein energy and multiple micronutrients.
Descriptive statistics are also presented stratified by supplement group for those with longitudinal pQCT data. All variables expressed in mean (SD),
except parity median (IQR) and n (% of total) for parity bands.
Welch two-sample t test: ap < .05, bp = .01, cp = .001. Mann–Whitney U test: dp = .05, ep = .01, fp = .001.
gParity available for 458 women with longitudinal pQCT data and for 338 without longitudinal pQCT.
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increased by 1.15 (0.55, 1.75)%, 0.41 (0.24, 0.58)%, and 0.47 (0.25,
0.69)%, respectively. Only tibia cortical CSA was found to
increase (0.20 [0.09, 0.31]%) (Fig. 1). After age adjustment, the
magnitude and significance of between-visit changes in mater-
nal plasma and urinary biochemistry (Fig. 2, Supplemental
Fig. S2) were broadly consistent with the unadjusted data
(Table 2, Supplemental Table S3). At the radius, the change
in BMC was inversely associated with maternal age (−0.04
[−0.07, −0.01]%/year), ie, the older the woman, the smaller
the increase, but no change was noted in cortical vBMD
(−0.02 [−0.05, 0.01]%/year). No significant age effects were
found at the tibia. Older maternal age was associated with a
greater increase in CTX (1.75 [0.57, 2.80]%/year) and a smaller
increase in PTH (−1.10 [−1.95, −0.23]%/year). There were no
significant associations with age among the other plasma or
any of the urinary analytes.
Adjusting for supplement group revealed a modifying effect
on changes in maternal bone measures and biochemistry after
controlling for age. Fig. 3A, B depict the age-adjusted differences
in change over time at the radius and tibia for three supplement
groups relative to the IFA group; Fig. 4 depicts the biochemistry.
The increase in radial cortical vBMD was lower for MMN and PE
than for IFA by −0.54 (−1.01, −0.07)% and −0.73 (−1.20,
−0.26)%, respectively. The increase in cortical CSA in MMN was
0.67 (0.10, 1.25)% greater than that of the IFA group. Tibial total
vBMD for PE + MMN was 0.76 (0.22, 1.30)% greater than the
IFA group. In contrast, no differences inmarkers of bone turnover
were found for any supplement group compared with IFA. While
Table 2. Bone Outcomes, Biochemistry, and Bone Turnover Markers for Pregnant Women With Longitudinal pQCT Measures at Booking
and P30
Booking P30 Δ sym%
4% Radius n = 435
Total vBMD (mg/cm3) 319.23 (44.98) 320.12 (45.44) 0.26 (0.25)
Trabecular vBMD (mg/cm3) 160.51 (35.63) 162.03 (34.71) 1.15 (0.30)c
Total CSA (mm2) 335.94 (42.09) 337.85 (44.21) 0.49 (0.31)
33% Radius n = 440
Total CSA (mm2) 119.82 (16.12) 119.49 (16.82) −0.34 (0.42)
Cortical vBMD (mg/cm3) 1239.66 (35.17) 1244.76 (37.32) 0.41 (0.09)c
Cortical BMC (mg/mm) 94.05 (10.77) 94.51 (10.99) 0.47 (0.11)c
Cortical CSA (mm2) 75.84 (8.17) 75.91 (8.32) 0.06 (0.11)
Cortical thickness (mm) 2.45 (0.23) 2.46 (0.23) 0.38 (0.35)
4% Tibia n = 407
Total vBMD (mg/cm3) 281.86 (36.08) 282.77 (35.83) 0.34 (0.10)c
Trabecular vBMD (mg/cm3) 190.49 (31.19) 191.26 (30.74) 0.46 (0.14)b
Total CSA (mm2) 945.65 (112.59) 944.46 (112.90) −0.13 (0.13)
38% Tibia n = 409
Total CSA (mm2) 377.60 (47.95) 378.28 (49.15) 0.15 (0.14)
Cortical vBMD (mg/cm3) 1230.23 (35.20) 1234.61 (37.60) 0.35 (0.04)c
Cortical BMC (mg/mm) 280.01 (34.20) 281.53 (34.27) 0.55 (0.07)c
Cortical CSA (mm2) 227.52 (26.26) 227.94 (26.13) 0.20 (0.06)c
Cortical thickness (mm) 4.07 (0.41) 4.08 (0.41) 0.13 (0.13)
Bone biochemistry and bone turnover markersd
β-CTX (ng/L, n = 293) 230 (66, 665) 290 (114, 685) 23.0 (3.64)c
P1NP (μg/L, n = 295) 59.7 (29.1, 140) 43.4 (21.3, 90.0) −32.4 (2.30)c
PTH (ng/L, n = 283) 27.4 (12.6, 51.9) 31.2 (13.6, 61.6) 13.2 (2.78)c
1,25(OH)2D (pmol/L, n = 205) 255 (181, 361) 314 (219, 433) 21.0 (1.65)
c
TALP (U/L, n = 464) 79.0 (44.7, 122) 106 (67.4, 172) 29.0 (1.53)c
Albumin (g/L, n = 464) 31.8 (25.8, 38.1) 25.5 (22.2, 30.0) −21.4 (0.56)c
Creatinine (μmol/L, n = 464) 36.3 (26.5. 48.9) 36.6 (25.9, 53.2) 1.08 (0.89)
Phosphate (mmol/L, n = 464) 1.05 (0.81, 1.34) 1.08 (0.85, 1.34) 2.99 (0.80)c
Calcium (mmol/L, n = 464) 2.25 (2.05, 2.41) 2.12 (1.97, 2.27) −5.36 (0.28)c
CalciumCorr (mmol/L, n = 464) 2.41 (2.27, 2.53) 2.41 (2.29, 2.51) 0.32 (0.19)
Magnesium (mmol/L, n = 464) 0.76 (0.66, 0.87) 0.75 (0.65, 0.86) −1.75 (0.42)c
P30 = 30 weeks’ gestation; vBMD = volumetric bone mineral density; CSA = cross-sectional area; BMC = bone mineral content; β-CTX = collagen type 1
cross-linked β-C-telopeptide; P1NP = type 1 procollagen N-terminal; PTH = parathyroid hormone; 1,25(OH)2D = 1,25-dihydroxyvitamin D; TALP = total
alkaline phosphatase; CalciumCorr = corrected using the Payne equation, ie, albumin-corrected plasma calcium (mmol/L) = measured plasma calcium
mmol/L + ([40-plasma albumin g/L]*0.02).
Between-visit differences are expressed as sympercents (Δ sym%). All pQCTmeasures expressed asmean (SD), biochemistry as GMean (5th centile, 95th
centile), change between visits as Δ Mean (SE)%.




dReference data for a separate group of non-pregnant non-lactating women can be found in Supplemental Table 4S.
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Fig 1. Pregnancy-related between-visit change in pQCT bone outcomes at the radius and tibia. Beta-coefficients of percentage between-visit change
(mean [95% confidence interval]) for pQCT bone outcomes at the radius and tibia. Model adjusted for maternal age only. vBMD= volumetric bonemineral
density; CSA = cross-sectional area; BMC = bone mineral content. ap < .05; bp < .01, cp < .001.
Fig 2. Pregnancy-related between-visit change in maternal bone turnover markers and analytes of bone biochemistry. Beta-coefficients of percentage
between-visit change (mean [95% confidence interval]) in maternal biochemistry and bone turnover markers. Model adjusted for maternal age only.
β-CTX = collagen type 1 cross-linked β-C-telopeptide; P1NP = type 1 procollagen N-terminal; PTH = parathyroid hormone; TALP = total alkaline phospha-
tase. ap < .05; bp < .01; cp < .001.
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Fig 3. Differences in pregnancy-related between-visit change between iron folate group and supplement groups in pQCT bone outcomes at the radius
and tibia. Beta-coefficients of percentage difference in change between supplement groups and IFA reference group (mean [95% confidence interval]) for
pQCT bone outcomes at the radius (A) and tibia (B). Model adjusted for maternal age and supplement group. IFA = iron folate; MMN = multi-micronutri-
ents; PE = protein energy; PE + MMN = protein energy and multi-micronutrients; vBMD = volumetric bone mineral density; CSA = cross-sectional area;
BMC = bone mineral content. ap < .05; bp < .01; cp < .001.
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albumin decreased overall, the decrease was 3.8 (−6.92, −0.72)%
and 3.7 (−6.66, −0.48)% greater in the PE and PE + MMN groups,
respectively, compared with IFA. Decreases in Mg in the PE
+ MMN group were 3.2 (−5.47, −0.85)% greater than the IFA
group (p < .01); however, this was attenuated after adjustment
for albumin. Although there was an increase in phosphate over-
all, this was significantly less in the PE (−8.1 [−12.45, −3.71]%)
and PE + MMN (−6.5 [−10.82, −2.11]%) groups compared with
IFA. The only urinary analyte where differences were found com-
pared with IFA was urinary phosphate creatinine ratio, where the
decrease in the MMN, PE, and PE + MMN groups was lower by
19.8 (4.13, 35.57)%, 16.1 (0.09, 32.19)%, and 19.4 (3.58, 35.02)%,
respectively.
Discussion
This study has shown that pregnancy-related bone mineral
mobilization is not evident in the appendicular skeleton of rural
Gambian women between the early second and mid-third tri-
mesters of pregnancy. In contrast, there was evidence of mineral
accretion in the cortical compartment of both the radius and
tibia, although the magnitude of the increases for cortical vBMD
and BMCwere no greater than 0.5%. There was also some limited
evidence of supplement modulation in the changes found in the
bone measures. Although the magnitudes of the pQCT changes
were modest and their clinical or physiological significance likely
to be minimal, they may still reflect alterations in maternal Ca
homeorhesis during pregnancy.
To date, few comparable studies have been conducted using
pQCT in pregnancy. In a study based in Cambridge (UK), we
recently reported decreases in maternal vBMD at the tibia with
HR-pQCT (total and cortical) and pQCT (total and trabecular).(22)
The Cambridge study had a similar design to the one presented
here, with identical pQCT scan sites imaged and the same proto-
col used at both centers, although the final visit occurred later in
pregnancy (34 to 36 weeks’ gestation, mean 35.5 weeks). Two
other studies have used pQCT technologies during gestation. A
Swiss study, using a different pQCT modality, with slightly differ-
ent scan sites, reported decreases in trabecular vBMD at the
radius during pregnancy.(21) In that study, no change in cortical
vBMD was observed, although their scan site was more distal
than the 33% site used in our study and will have contained
some trabecular bone. A recent pQCT study from an ethnically
diverse US population reported no changes in maternal cortical
bone outcomes.(31)
Studies that have used DXA and its precursors to image the
forearm have mostly found little evidence of mineral mobiliza-
tion at the trabecular-rich distal radius,(10,12,20) consistent with
the findings from our Gambian pQCT study. Studies that have
used DXA to scan the 33% radius (almost exclusively cortical
bone) reported no evidence of mineral mobilization.(10,12,18,20)
However, studies of pregnancy and lactation have suggested
conservation of bone mineral at cortical-rich sites of the appen-
dicular skeleton.(18) Our pQCT data also suggest conservation
and possible accretion of bone mineral at cortical-rich sites in
the peripheral skeleton during pregnancy.
As has been shown in previous Gambian studies,(32,33) the
NPNL reference group had high PTH and low urinary calcium
excretion compared with typical Western values, indicative of
adaptation to their low calcium intake.(34) At the booking visit
(early second trimester), the pregnant women in the pQCT study
Fig 4. Differences in pregnancy-related between-visit change between iron folate group and supplement groups in maternal bone turnover markers and
analytes of bone biochemistry. Beta-coefficients of percentage difference in change between supplement groups and IFA reference group (mean [SE]) for
maternal biochemistry and bone turnover markers. Model adjusted for maternal age and supplement group. IFA = iron folate; MMN = multi-micronutri-
ents; PE = protein energy; PE + MMN = protein energy andmulti-micronutrients; β-CTX = collagen type 1 cross-linked β-C-telopeptide; P1NP = type 1 pro-
collagen N-terminal; PTH = parathyroid hormone; TALP = total alkaline phosphatase. ap < .05; bp < .01; cp < .001.
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had lower PTH, CTX, albumin, plasma phosphate, and plasma
magnesium plus higher 1,25(OH)2vitamin D and urinary calcium
excretion than the NPNL reference group. As such, these findings
are in line with the pregnancy-related differences expected due
to metabolic changes and hemodilution.(35) Unlike CTX, where
decreases in the second trimester are considered to reflect
hemodilution,(35) there was no indication of lower P1NP concen-
trations at booking, possibly suggesting a subtle shift in the bal-
ance of bone turnover in these women in favor of formation at
this stage of pregnancy.
In contrast to finding evidence of a lack of maternal bonemin-
eral mobilization with pQCT, there were significant changes in
both CTX and P1NP concentrations between the early second
to third trimesters in the Gambian women. In keeping with other
studies of pregnancy,(6,36–38) we observed increases in CTX
between early and late pregnancy; however, at both booking
and P30, mean CTX concentration was lower than that found in
the local population of NPNL (Supplemental Fig. S3). Few studies
have been published using P1NP, and these report increases dur-
ing the third trimester,(6,37) a pattern also reported for another
bone formation marker, procollagen type 1 C propeptide
(P1CP).(6,10) The physiological significance of this is difficult to
interpret because increases in P1NP and P1CP in late gestation
may be related to fetal production rather than maternal.(6) Our
findings, however, indicate that P1NP decreased into the third
trimester of pregnancy in the Gambian women, suggesting a
decrease in bone formation and a shift in the balance of bone
turnover in favor of resorption.
The lack of evidence of mobilization from appendicular bone
in the context of increased resorption (versus booking) and
reduced bone formation (versus booking and NPNL) does not
preclude that mineral mobilization may occur elsewhere in the
maternal skeleton. However, taking the BTM data in context,
and noting the reduction in urinary calcium output at P30 below
that of the NPNL reference group, it appears more likely that
maternal mineral reserves may be preserved (at least to
30 weeks) by reduced bone turnover and increased renal cal-
cium conservation. It is possible that these findings represent a
further manifestation of metabolic adaptation to the low calcium
intake in this rural Gambian population. An early study in The
Gambia(39) reported elevated concentrations compared with
Western values of calcitonin, a hormone that increases during
gestation and may have a physiological role in protecting the
skeleton during pregnancy.(35) It is also possible that the appar-
ent conservation of appendicular bone mineral, especially at
the distal tibia, may relate to the fact that almost all women in
this rural region are involved in physically demanding farming
throughout pregnancy, and that walking, often with heavy
head-loads, is the primary mode of transport.(40)
Unlike many of the studies in the literature, the age range of
this study cohort was very broad, with women aged between
18 and 45 years recruited. In addition, comparedwith other stud-
ies, the mean parity of these women was high and highly corre-
lated with age. Maternal age, and by proxy parity, had little
impact as a predictor of between-visit changes in bone and bio-
chemical measures, but, interestingly, significant inverse associa-
tions with age were found for the increases in cortical BMC at the
radius and PTH concentrations, plus a positive association for the
increase in CTX. This indicates that the older the mother, the
smaller the increases in cortical BMC and PTH but the greater
the increase in CTX. This pattern suggests that being older in this
cohort was associated with a greater increase in resorption
between the two pregnancy visits 3 to 4 months apart. It is
possible that this reflects age-related increases in bone resorp-
tion superimposed on those related specifically to pregnancy.
This possibility would require comparison with an age-matched,
non-pregnant reference group of women to have been scanned
over the same time period as the pregnant women, which was
not possible in our study.
Strengths
This study presents, to the best of our knowledge, the first use of
pQCT during pregnancy in sub-Saharan Africa. In addition, it is
the largest study to date anywhere to use pQCT in pregnancy.
While some studies have only measured the non-load-bearing
forearm, we investigated changes at the load-bearing tibia in
addition to the radius. By investigating changes in bone turnover
markers and maternal biochemistry, we were able to obtain
information about possible systemic changes in maternal bone
metabolism. These data complement our pQCT scans of the
peripheral skeleton and may indirectly provide insights into
potential changes occurring in the axial skeleton. Although we
did not have an NPNL control arm in the study, we were able
to use NPNL reference values for plasma and urinary biochemis-
try from another study in this rural Gambian population.
Limitations
The limitations of this work include that we cannot determine
whether mineral mobilization may have occurred in the first tri-
mester of pregnancy or for any natural age-related changes in
bone. Also, because the third trimester visit was at around
30 weeks’ gestation and because there is evidence that late
pregnancy is a resorptive state, this will have limited the poten-
tial to detect changes in the appendicular skeleton that may
have occurred closer to term. Because we were unable to use
DXA during pregnancy, it is difficult to interpret whatmay be tak-
ing place in the axial skeleton. Another limitation is that,
although we found no evidence of mineral mobilization in the
appendicular skeleton using pQCT, it is conceivable that mobili-
zation could occur without an apparent decrease in vBMD
through other mechanisms that cannot be detected with
single-slice pQCT, such as reorganization of bone microarchitec-
ture.(22) Women taking part in the study all received Gambian
standard-of-care IFA supplementation, and, as such, represented
the control arm for this study. We do not think it is likely that
women in the IFA only could have benefited from improved
nutrition compared with non-study women in the population,
while these women may have received additional health care
because of regular contact with the study team before and dur-
ing the main trial. The lack of consistent findings when stratified
by supplement group may suggest that maternal supplementa-
tion had little effect on calcium and bone metabolism in preg-
nancy, but it should be noted that none of the supplements
contained calcium and the supplements were not designed to
specifically impact bone. Further limitations include the lack of
pQCT measures in an age-related NPNL group, the difficulty of
interpreting changes in plasma and urine data during a period
of physiological alterations in hemodilution and glomerular fil-
tration rate, and that the women in the study had received
health care before and during pregnancy beyond what is typical
in this community because of their involvement in the ENID trial.
These data provide an insight into maternal bone mineral
metabolism during pregnancy in the appendicular skeleton of
rural Gambian women. To date, these are the only such
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densitometric data collected during pregnancy in sub-Saharan
Africa. No evidence of bone mineral mobilization was found at
the radius and tibia, but changes observed in BTMs between
the second and third trimesters suggest a shift in the ratio of
resorption to formation, although both CTX and P1NP concentra-
tions were lower than the NPNL reference group at both visits. In
contrast, small but significant increases in vBMD and BMC were
observed at both trabecular- and cortical-rich sites in the radius
and tibia, representing both load-bearing and non-load-bearing
sites of the appendicular skeleton. Although the magnitudes of
these increases were modest in this index pregnancy, it is possi-
ble that, in populations where high parity is common, these
small increases in vBMD and BMC could increase bone strength
if accumulated across multiple pregnancies. Research with pQCT
and DXA in populations where parity is high has previously sug-
gested potential beneficial adaptations related to high parity.(41)
Further, we observed some modulation by dietary supplement
group, but these effects were marginal in magnitude. In conclu-
sion, maternal bone mineral does not appear to be mobilized
from the appendicular skeleton during pregnancy in this popula-
tion on a low Ca diet, but there is evidence that maternal mineral
reserves may be preserved through reduced bone turnover and
increased renal calcium conservation.
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